Abstract:AMPLATZER vascular plug is a widely used embolic agent. In the present paper, we present a case of an 86-year-old female patient who underwent bilateral ureteral occlusion by means of AMPLATZER vascular plug II coupled to n-butyl cyanoacrylate (NBCA) because of recurring pyelonephritis following cystectomy with subsequent bilateral ureterosigmoidostomy (sec. Mainz type II).
“…Amplatzer vascular plugs (AVP)which are approved for endovascular applicationscan be used for ureteral occlusion either with a latex cover [38] or as a scaffold to secure additional embolisates (coils and/or glue) [24,25,39,40].…”
Section: Amplatzer Vascular Plugmentioning
confidence: 99%
“…Other authors have raised the concern that a latex-covered AVP may dislocate and suggested using the AVP as a scaffold for additional glue embolization with high clinical success rates of 90 -100 % during follow-up (7 -14 months) [24,25,39,40].…”
“…Amplatzer vascular plugs (AVP)which are approved for endovascular applicationscan be used for ureteral occlusion either with a latex cover [38] or as a scaffold to secure additional embolisates (coils and/or glue) [24,25,39,40].…”
Section: Amplatzer Vascular Plugmentioning
confidence: 99%
“…Other authors have raised the concern that a latex-covered AVP may dislocate and suggested using the AVP as a scaffold for additional glue embolization with high clinical success rates of 90 -100 % during follow-up (7 -14 months) [24,25,39,40].…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.